Sofosbuvir and Daclatasvir Improve Platelet Factor 4 Levels in Chronic Hepatitis C Patients
Fatma A. Hamoud, Noha E. Esheba, Mohamed A. Saad, Mahmoud F. Selim & Mohamed A. Safa · Asian Journal of Research and Reports in Hepatology · 2022
Background: Worldwide, more than 170 million persons have hepatitis C virus (HCV) infection, of whom 71 million have chronic infection. Egypt is the country with the highest HCV prevalence worldwide–antibody prevalence in Egypt was estimated at 11.9% in a 2018 meta-analysis with...
Open access
Research Article